Wistar Wire: 2011

wistar
A news segment featuring Wistar Professor Louise C. Showe, Ph.D., aired on CBS3 on December 21, 2011 in the five o'clock broadcast. The segment discussed her work toward developing a blood test for lung cancer.
Cancer, Genes
wistar
The Wistar Institute has a 30-year tradition of donating toys to children in oncology unit of the Children’s Hospital of Pennsylvania. This December, Wistar employees gave generously and raised $2,300 for the cause.
Cancer
wistar
One reason why lung cancer is one of the deadliest forms of cancer in the United States is that it is so difficult to detect at its earliest stages, when treatment is most effective. But what if a simple blood test—no more invasive than having your cholesterol or blood sugar levels checked—could do the trick?
Cancer, Genes
wistar
The Wistar Institute today announced that it has signed a funding agreement with the Wellcome Trust, a United Kingdom-based charity, to support the development of a new drug to treat cancers associated with Epstein-Barr virus (EBV). The Seeding Drug Discovery Award of up to $4.7 million will support on-going translational research in the laboratory of Wistar Professor Paul M. Lieberman, Ph.D. If successful, the new therapeutic could be the first to treat EBV-related cancer by attacking the virus as it remains dormant in a patient’s cells.
Cancer